MiR-421 regulates apoptosis of BGC-823 gastric cancer cells by targeting caspase-3

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 13, 2014, Pages 5463-5468

  Wu, Jian Hong ^a   Yao, Yong Liang ^a   Gu, Tao ^a   Wang, Ze You ^b   Pu, Xiong Yong ^a   Sun, Wang Wei ^a   Zhang, Xian ^a   Jiang, Yi Biao ^a   Wang, Jian Jun ^a  

^a JIANGSU UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Caspase 3; Gastric cancer; MiR 421

Indexed keywords

CASPASE 3; MICRORNA; MIRN421 MICRORNA, HUMAN; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

APOPTOSIS; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; STOMACH TUMOR; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; UPREGULATION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MICRORNAS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; STOMACH NEOPLASMS; UP-REGULATION;

EID: 84905400080     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.13.5463     Document Type: Article

References (37)

1. Ali Z, Deng Y and Ma C (2012). Progress of research in gastric cancer. J Nanosci Nanotechnol, 12, 8241-8.
2. Bartel DP (2009). MicroRNAs: target recognition and regulatory functions. Cell, 136, 215-33.
3. Brennecke J, Stark A, Russell RB, et al (2005). Principles of microRNA-target recognition. PLoS Biol, 3, 85.
4. Chen L, Tang Y, Wang J, et al (2013). MiR-421 induces cell proliferation and apoptosis resistance in human nasopharyngeal carcinoma via downregulation of FOXO4. Biochem Biophys Res Commun, 435, 745-50.
5. Du L, Pertsemlidis A (2012). MicroRNA regulation of cell viability and drug sensitivity in lung cancer. Expert Opin Biol Ther, 12, 1221-39.
6. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
7. Guo J, Miao Y, Xiao B, et al (2009). Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol, 24, 652-7.
8. He L, Hannon GJ (2004). MicroRNAs: Small RNAs with a big role in gene regulation. Nat Rev Genet, 5, 522-31.
9. Hoshi T, Sasano H, Kato K, et al (1998). Immunohlstochemistry of Caspase-3/cpp32 in human stomach and its correlation with ceil proliferation and apoptosis. Anticancer Res, 18, 4347-53.
10. Hsu KW, Hsieh RH, Huang KH, et al (2012). Activation of the Notch1/STAT3/Twist signaling axis promotes gastric cancer progression. Carcinogenesis, 33, 1459-67.
11. Hu H, Du L, Nagabayashi G, et al (2010). ATM is down-regulated by N-Myc-regulated microRNA-421. Proc Natl Acad Sci USA, 107, 1506-11.
12. Hu YR, Liu SQ, Tian YX, et al (2009). Effects of a disintegrin, adinbitor, from gloydius blomhoffi brevicaudus on Akt signal pathway and proliferation, migration and apoptosis of SSMC7721 cells. Zhong Guo Sheng Wu Hua Xue Yu Fen Zi ShengWu Xue Bao, 25, 662-8.
13. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
14. Kania J, Konturek SJ, Marlicz K, et al (2003). Expression of survivin and caspase-3 in gastric cancer. Dig Dis Sci, 48, 266-71.
15. Kim K, Chun KH, Suh PG et al (2011). Alterations in cell proliferation related gene expressions in gastric cancer. Crit Rev Eukaryot Gene Expr, 21, 237-54.
16. Kong D, Piao YS, Yamashita S, et al (2012). Inflammation-induced repression of tumor suppressor miR-7 in gastric tumor cells. Oncogene, 31, 3949-60.
17. Konishi H, Ichikawa D, Komatsu S, et al (2012). Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre-and post-operative plasma. Br J Cancer, 106, 740-7.
18. Krajewska M, Wang HG, Krajewski S, et al (1997). Immunohistochemical analysis of in vivo patterns of expression of CPP32 (caspase-3), a cell death protease. Cancer Res, 57, 1605-11.
19. Lee S, Vasudevan S (2013). Post-transcriptional stimulation of gene expression by microRNAs. Adv Exp Med Biol, 768, 97-126.
20. Liu H (2009). MicroRNAs in breast cancer initiation and progression. Cell Mol Life Sci, 69, 3587-99.
21. Liu XX, Li XJ, Zhang B, et al (2011). MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11. FEBS Lett, 585, 1363-7.
22. Menendez P, Villarejo P, Padilla D, et al (2013). Diagnostic and prognostic significance of serum microRNAs in colorectal cancer. J Surg Oncol, 107, 217-20.
23. Oshima H, Ishikawa T, Yoshida GJ, et al (2013). TNF-α/TNFR1 signaling promotes gastric tumorigenesis through induction of Noxo1 and Gna14 in tumor cells. Oncogene, 356, [Epub ahead of print].
24. Oulas A, Boutla A, Gkirtzou K, et al (2009). Prediction of novel microRNA genes in cancerassociated genomic regions-a combined computational and experimental approach. Nucleic Acids Res, 37, 3276-87.
25. Peng S, Zeng X, Li X, et al (2009). Multi-class cancer classification through gene expression profiles: microRNA versus Mrna. J Genet Genomics, 36, 409-16.
26. Peralta-Zaragoza O, Bermudez-Morales VH, Madrid-Marina V (2010). RNA interference: biogenesis molecular mechanisms and its applications in cervical cancer. Rev Invest Clin, 62, 63-80.
27. Saeki N, Ono H, Sakamoto H et al (2013). Genetic factors related to gastric cancer susceptibility identified using a genomewide association study. Cancer Sci, 104, 1-8.
28. Samali A, Cai J, Zhivotovsky B, et al (1999). Presence of a pre-apoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of jurkat cells. EMBO J, 18, 2040-8.
29. Segura MF, Greenwald HS, Hanniford D, et al (2012). MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy. Carcinogenesis, 33, 1823-32.
30. Tang G, Tang X (2013). Short tandem target mimic: a long journey to the engineered molecular landmine for selective destruction/blockage of microRNAs in plants and animals. J Genet Genomics, 40, 291-6.
31. Thiel A, Ristimaki A (2012). Gastric cancer: basic aspects. Helicobacter, 1, 26-9.
32. Wei MC, Zong WX, Cheng EH, et al (2011). Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science, 292, 727-30.
33. Xiao LJ, Zhao S, Zhao EH, et al (2013). Clinicopathological and prognostic significance of Ki-67, caspase-3 and p53 expression in gastric carcinomas. Oncol Lett, 6, 1277-84.
34. Xu L, Dai WQ, Xu XF, et al (2012). Effects of Multiple-target anti-microRNA antisense oligodeoxyribonucleotides on proliferation and migration of gastric cancer cells. Asian Pac J Cancer Prev, 13, 3203-7.
35. Yang L (2006). Incidence and mortality of gastric cancer in China. World J Gastroenterol, 12, 17-20.
36. Yao YL, Wu XY, Wu JH, et al (2013). Effects of microRNA-106 on proliferation of gastric cancer cell through regulating p21 and E2F5. Asian Pac J Cancer Prev, 14, 2839-43.
37. Yu JW, Wu JG, Zheng LH, et al (2009). Influencing factors and clinical significance of the metastatic lymph nodes ratio in gastric adenocarcinoma. J Exp Clin Cancer Res, 28, 55.